View Archive »
About The Cover
The cover for issue 40 of Oncotarget features Figure 7, "Fap1-inhibition with SLV peptide increases Fas and Gsk3β phosphorylation in CD133+ cells in a murine xenograft model," by Huang, et al.
|
|
Table of Contents
Research Papers: Immunology
|
| Development of a preclinical humanized mouse model to evaluate acute toxicity of an influenza vaccine |
|
https://doi.org/10.18632/oncotarget.25399
|
| 25751-25763 |
Research Papers
|
| Preclinical validation of B cell maturation antigen BCMA as a target for T cell immunotherapy of multiple myeloma |
|
https://doi.org/10.18632/oncotarget.25359
|
| 25764-25780 |
|
| Suppression of focal adhesion formation may account for the suppression of cell migration invasion and growth of nonsmall cell lung cancer cells following treatment with polyisoprenylated cysteinyl amide inhibitors |
|
https://doi.org/10.18632/oncotarget.25372
|
| 25781-25795 |
|
| Camptothecin exhibits topoisomerase1independent KMT1A suppression and myogenic differentiation in alveolar rhabdomyosarcoma cells |
|
https://doi.org/10.18632/oncotarget.25376
|
| 25796-25807 |
|
| Metformin exerts antitumor activity via induction of multiple death pathways in tumor cells and activation of a protective immune response |
|
https://doi.org/10.18632/oncotarget.25380
|
| 25808-25825 |
|
| Clinical validation of the Tempus xO assay |
|
https://doi.org/10.18632/oncotarget.25381
|
| 25826-25832 |
|
| VX984 is a selective inhibitor of nonhomologous end joining with possible preferential activity in transformed cells |
|
https://doi.org/10.18632/oncotarget.25383
|
| 25833-25841 |
|
| Synthetic lethality in CCNE1amplified high grade serous ovarian cancer through combined inhibition of Pololike kinase 1 and microtubule dynamics |
|
https://doi.org/10.18632/oncotarget.25386
|
| 25842-25859 |
|
| Platelet activation parameters and plateletleucocyteconjugate formation in glioblastoma multiforme patients |
|
https://doi.org/10.18632/oncotarget.25395
|
| 25860-25876 |
|
| Efficient lysis of Bchronic lymphocytic leukemia cells by the plantderived sesquiterpene alcohol αbisabolol a dual proapoptotic and antiautophagic agent |
|
https://doi.org/10.18632/oncotarget.25398
|
| 25877-25890 |
|
| Inhibition of Fas associated phosphatase 1 Fap1 facilitates apoptosis of colon cancer stem cells and enhances the effects of oxaliplatin |
|
https://doi.org/10.18632/oncotarget.25401
|
| 25891-25902 |
|
| CHL1 gene acts as a tumor suppressor in human neuroblastoma |
|
https://doi.org/10.18632/oncotarget.25403
|
| 25903-25921 |
|
| Epigenetic dysregulation of TET2 in human glioblastoma |
|
https://doi.org/10.18632/oncotarget.25406
|
| 25922-25934 |
|
| Subclassification survival prediction and drug target analyses of chemotherapynaïve muscleinvasive bladder cancer with a molecular screening |
|
https://doi.org/10.18632/oncotarget.25407
|
| 25935-25945 |
|
| Low expression of G proteincoupled oestrogen receptor 1 GPER is associated with adverse survival of breast cancer patients |
|
https://doi.org/10.18632/oncotarget.25408
|
| 25946-25956 |
|
| Targeted DNA sequencing of nonsmall cell lung cancer identifies mutations associated with brain metastases |
|
https://doi.org/10.18632/oncotarget.25409
|
| 25957-25970 |
|
| Surface expression of Cytokine ReceptorLike Factor 2 increases risk of relapse in pediatric acute lymphoblastic leukemia patients harboring IKZF1 deletions |
|
https://doi.org/10.18632/oncotarget.25411
|
| 25971-25982 |
|
| Activated matriptase as a target to treat breast cancer with a drug conjugate |
|
https://doi.org/10.18632/oncotarget.25414
|
| 25983-25992 |
|
| Anion exchanger 2 suppresses cellular movement and has prognostic significance in esophageal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.25417
|
| 25993-26006 |
|
| Impact of aldosteroneproducing cell clusters on diagnostic discrepancies in primary aldosteronism |
|
https://doi.org/10.18632/oncotarget.25418
|
| 26007-26018 |
|
| A novel ex vivo highthroughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia |
|
https://doi.org/10.18632/oncotarget.25419
|
| 26019-26031 |
|
| CD44 positive and sorafenib insensitive hepatocellular carcinomas respond to the ATPcompetitive mTOR inhibitor INK128 |
|
https://doi.org/10.18632/oncotarget.25430
|
| 26032-26045 |
|
| BCL2 and BCLXL selective inhibitors decrease mitochondrial ATP production in breast cancer cells and are synthetically lethal when combined with 2deoxyDglucose |
|
https://doi.org/10.18632/oncotarget.25433
|
| 26046-26063 |
|
| Highthroughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomaviruspositive or negative cell lines |
|
https://doi.org/10.18632/oncotarget.25436
|
| 26064-26071 |
|
| Induction of apoptosis and suppression of tumor growth by Nur77derived Bcl2 converting peptide in chemoresistant lung cancer cells |
|
https://doi.org/10.18632/oncotarget.25437
|
| 26072-26085 |
|
| Twentysevennucleotide repeat insertion in the rplV gene confers specific resistance to macrolide antibiotics in Staphylococcus aureus |
|
https://doi.org/10.18632/oncotarget.25441
|
| 26086-26095 |
|
| A novel combinatorial treatment option for metastatic uveal melanoma |
|
https://doi.org/10.18632/oncotarget.25445
|
| 26096-26108 |
|
| Conception synthesis and characterization of a rofecoxibcombretastatin hybrid drug with potent cyclooxygenase2 COX2 inhibiting and microtubule disrupting activities in colon cancer cell culture and xenograft models |
|
https://doi.org/10.18632/oncotarget.25450
|
| 26109-26129 |
|
| Heat shock protein 90 inhibitors augment endogenous wildtype p53 expression but downregulate the adenovirallyinduced expression by inhibiting a proteasome activity |
|
https://doi.org/10.18632/oncotarget.25452
|
| 26130-26143 |
|
| Lossoffunction mutations in Znfinger DNAbinding domain of HNF4A cause aberrant transcriptional regulation in liver cancer |
|
https://doi.org/10.18632/oncotarget.25456
|
| 26144-26156 |
|
| Lymph microvascularization as a prognostic indicator in neuroblastoma |
|
https://doi.org/10.18632/oncotarget.25457
|
| 26157-26170 |
|
| Translation terminationdependent deadenylation of MYC mRNA in human cells |
|
https://doi.org/10.18632/oncotarget.25459
|
| 26171-26182 |
|
| Association of mRNA expression of iron metabolismassociated genes and progression of nonalcoholic steatohepatitis in rats |
|
https://doi.org/10.18632/oncotarget.25488
|
| 26183-26194 |
|
| Concomitant driver mutations in advanced EGFRmutated nonsmallcell lung cancer and their impact on erlotinib treatment |
|
https://doi.org/10.18632/oncotarget.25490
|
| 26195-26208 |
Clinical Research Papers
|
| Diffusionweighted MRI in the evaluation of the thyroid nodule: Comparison between integratedshimming EPI and conventional 3Dshimming EPI techniques |
|
https://doi.org/10.18632/oncotarget.25279
|
| 26209-26216 |
|
| The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians |
|
https://doi.org/10.18632/oncotarget.25439
|
| 26217-26225 |
Reviews
|
| Modeling small cell lung cancer SCLC biology through deterministic and stochastic mathematical models |
|
https://doi.org/10.18632/oncotarget.25360
|
| 26226-26242 |
|
| Targeting the SET and RINGassociated SRA domain of ubiquitinlike PHD and ring finger–containing 1 UHRF1 for anticancer drug development |
|
https://doi.org/10.18632/oncotarget.25425
|
| 26243-26258 |
|
| Role of p27Kip1 as a transcriptional regulator |
|
https://doi.org/10.18632/oncotarget.25447
|
| 26259-26278 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
